Insider Transactions in Q2 2023 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,777
+20.27%
|
-
|
|
May 07
2023
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,323
-9.01%
|
$204,424
$88.74 P/Share
|
|
May 07
2023
|
Bernard J Zovighian CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,003
+16.25%
|
-
|
|
May 07
2023
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-1.16%
|
$11,792
$88.74 P/Share
|
|
May 07
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
2,154
-6.72%
|
$189,552
$88.74 P/Share
|
|
May 07
2023
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
4,708
+12.8%
|
-
|
|
May 07
2023
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.13%
|
$19,712
$88.74 P/Share
|
|
May 07
2023
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
3,355
+1.91%
|
-
|
|
May 07
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,004
-13.08%
|
$264,352
$88.74 P/Share
|
|
May 07
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,062
+20.88%
|
-
|
|
May 07
2023
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-8.37%
|
$160,336
$88.74 P/Share
|
|
May 07
2023
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,413
+13.56%
|
-
|
|
May 07
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
2,583
-1.23%
|
$227,304
$88.74 P/Share
|
|
May 07
2023
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
5,415
+2.51%
|
-
|
|
May 07
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,968
-4.87%
|
$261,184
$88.74 P/Share
|
|
May 07
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
4,767
+7.25%
|
-
|
|
May 05
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,635
-9.11%
|
$495,880
$88.62 P/Share
|
|
May 04
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
344
-1.24%
|
$30,272
$88.1 P/Share
|
|
May 04
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
396
-0.19%
|
$34,848
$88.1 P/Share
|
|
May 04
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
441
-2.54%
|
$38,808
$88.1 P/Share
|
|
May 04
2023
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
370
-1.75%
|
$32,560
$88.1 P/Share
|
|
May 04
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
496
-0.8%
|
$43,648
$88.1 P/Share
|
|
May 04
2023
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-1.5%
|
$24,552
$88.1 P/Share
|
|
May 04
2023
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-1.0%
|
$10,208
$88.1 P/Share
|
|
May 04
2023
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-0.02%
|
$3,344
$88.1 P/Share
|
|
May 03
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-1.17%
|
$28,449
$87.81 P/Share
|
|
May 03
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-0.19%
|
$33,321
$87.81 P/Share
|
|
May 03
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-2.43%
|
$37,671
$87.81 P/Share
|
|
May 03
2023
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-1.67%
|
$31,233
$87.81 P/Share
|
|
May 03
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Bona fide gift
|
Indirect |
5,715
-4.87%
|
-
|
|
May 03
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
468
-0.75%
|
$40,716
$87.81 P/Share
|
|
May 03
2023
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-1.49%
|
$24,447
$87.81 P/Share
|
|
May 03
2023
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
103
-0.88%
|
$8,961
$87.81 P/Share
|
|
May 03
2023
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.02%
|
$3,219
$87.81 P/Share
|
|
Apr 28
2023
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
12,270
-51.08%
|
$1,067,490
$87.2 P/Share
|
|
Apr 28
2023
|
Robert W.A. Sellers SVP, Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
12,270
+33.81%
|
$429,450
$35.2 P/Share
|
|
Apr 14
2023
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.26%
|
-
|
|
Apr 14
2023
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-12.54%
|
$1,669,500
$84.36 P/Share
|
|
Apr 14
2023
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-10.98%
|
-
|
|
Apr 14
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+24.54%
|
$1,028,125
$35.2 P/Share
|
|
Apr 06
2023
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
6,640
-3.78%
|
$551,120
$83.1 P/Share
|
|
Apr 06
2023
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,640
+3.64%
|
$232,400
$35.2 P/Share
|
|
Apr 06
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.67%
|
$558,175
$83.09 P/Share
|
|
Apr 06
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.82%
|
$235,375
$35.2 P/Share
|